CVS Overzicht aandelen
CVS Health Corporation biedt gezondheidsoplossingen in de Verenigde Staten. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 5/6 |
| Toekomstige groei | 2/6 |
| Prestaties in het verleden | 1/6 |
| Financiële gezondheid | 2/6 |
| Dividenden | 5/6 |
Beloningen
Risicoanalyse
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
US$103.00
FV
42.6% undervalued intrinsic discount18.02%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
about 1 month ago author updated this narrative
US$68.35
FV
13.6% undervalued intrinsic discount4.65%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
31users have followed this narrative
6 days ago author updated this narrative
US$62.09
FV
4.8% undervalued intrinsic discount7.00%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
about 2 months ago author updated this narrative
CVS Health Corporation Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$59.08 |
| 52 Week Hoogtepunt | US$83.25 |
| 52 Week Laag | US$52.71 |
| Bèta | 0.54 |
| 11 maand verandering | 5.86% |
| 3 maanden verandering | 2.96% |
| 1 Jaar Verandering | -13.73% |
| 33 jaar verandering | -36.23% |
| 5 jaar verandering | -21.22% |
| Verandering sinds IPO | 8,898.94% |
Recent nieuws en updates
Recent updates
There May Be Some Bright Spots In CVS Health's (NYSE:CVS) Earnings
Nov 19
CVS Health: Cheap But No Signs Of Turnaround (Yet)
Nov 06CVS Health (NYSE:CVS) Has A Somewhat Strained Balance Sheet
Nov 03CVS Health Stock Dip: Undervalued And Ready For A Turnaround
Oct 24CVS Health: Glenview's Activism Ramps Up Pressure On Management
Sep 30CVS Health: At Least There's A Valuable Lesson (Rating Downgrade)
Sep 10A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price
Aug 08CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run
Aug 07Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden
Jul 21CVS Health: A Better Investment Than Walgreens Boots Alliance
Jul 09Vltava Fund - CVS Health Corp.: Why We Sold CVS
Jul 03CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell
Jun 21The Correct Play On CVS Health
Jun 06CVS Health: Downside Movement Is Overdramatic
May 26CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity
May 15We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now
May 10CVS Health: A Terrible Earnings Report, But An Undervalued Stock
May 04CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 03CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot
Apr 22Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)
Apr 14CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date
Apr 10Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?
Mar 27CVS Health: Better Times Likely Ahead
Mar 12CVS Health: Lower Guidance But Risk/Reward Remains Attractive
Feb 15CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance
Feb 07CVS Health: Back In The Buy Column
Jan 21Rendement voor aandeelhouders
| CVS | US Healthcare | US Markt | |
|---|---|---|---|
| 7D | -1.7% | -0.02% | 0.7% |
| 1Y | -13.7% | 4.7% | 32.2% |
Rendement versus industrie: CVS presteerde slechter dan de US Healthcare -sector, die het afgelopen jaar een rendement van 4.7 % opleverde.
Rendement versus markt: CVS presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 32.2 % opleverde.
Prijsvolatiliteit
| CVS volatility | |
|---|---|
| CVS Average Weekly Movement | 5.8% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiele aandelenkoers: CVS heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 6% ) van CVS is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1996 | 259,500 | J. Joyner | www.cvshealth.com |
CVS Health Corporation biedt gezondheidsoplossingen in de Verenigde Staten. Het is actief via de segmenten Health Care Benefits, Health Services en Pharmacy & Consumer Wellness. Het Health Care Benefits segment biedt traditionele, vrijwillige en consumentgerichte zorgverzekeringsproducten en aanverwante diensten.
CVS Health Corporation Samenvatting
| CVS fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$75.32b |
| Inkomsten(TTM) | US$5.02b |
| Inkomsten(TTM) | US$367.25b |
14.8x
Koers/Winstverhouding0.2x
P/S-verhoudingIs CVS overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| CVS resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$367.25b |
| Kosten van inkomsten | US$316.53b |
| Brutowinst | US$50.71b |
| Overige uitgaven | US$45.70b |
| Inkomsten | US$5.02b |
Laatst gerapporteerde inkomsten
Sep 30, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 3.99 |
| Brutomarge | 13.81% |
| Nettowinstmarge | 1.37% |
| Schuld/Eigen Vermogen Verhouding | 85.4% |
Hoe presteerde CVS op de lange termijn?
Bekijk historische prestaties en vergelijking